Safety of Ultracet (Tramadol/Acetaminophen) in a 16-Year-Old
Ultracet is not recommended for use in patients under 16 years of age as its safety and efficacy have not been established in this population. 1
FDA Labeling and Age Restrictions
The FDA drug label for tramadol (a component of Ultracet) explicitly states: "The safety and efficacy of tramadol hydrochloride in patients under 16 years of age have not been established. The use of tramadol hydrochloride in the pediatric population is not recommended." 1
For dosing purposes, children weighing more than 40 kg are typically dosed as adults for many medications, but this general principle does not override specific age restrictions for tramadol. 2
While some medications define adult dosing as beginning at 15 years of age, tramadol specifically has a contraindication for those under 16 years. 2, 1
Risks and Concerns
Tramadol has a dual mechanism of action (opioid and norepinephrine/serotonin reuptake inhibitor), which increases the risk profile compared to single-mechanism analgesics. 2
Potential adverse effects of tramadol include:
Alternative Pain Management Options for Adolescents
For mild to moderate pain in adolescents, acetaminophen alone can be considered as a first-line agent:
Ibuprofen can be used as an alternative or in combination with acetaminophen:
Monitoring if Tramadol Must Be Used (in exceptional circumstances only)
If, despite the contraindication, a clinical decision is made to use tramadol in a 16-year-old (approaching 17) due to exceptional circumstances:
Remember that the combination of tramadol with acetaminophen (as in Ultracet) does not eliminate the age restriction concerns, despite potentially allowing for lower doses of tramadol. 5, 6
Conclusion
The evidence clearly indicates that Ultracet should not be used in patients under 16 years of age due to safety concerns and explicit FDA labeling. Alternative pain management strategies using acetaminophen and/or ibuprofen should be considered instead.